[Ip-health] Pharmalot: Most Americans believe prescription drug prices are unreasonable

Zack Struver zack.struver at keionline.org
Thu Sep 29 07:53:51 PDT 2016

Ed Silverman's story on the September 2016 Kaiser Family Foundation Health
Tracking Poll is below.

The full poll results are here:

​Most Americans believe prescription drug prices are unreasonable​

​By ED SILVERMAN @Pharmalot

SEPTEMBER 29, 2016​

​​Roughly 8 in 10 Americans believe that prices for prescription drugs are
unreasonable and support various ideas to lower costs, such as allowing
Medicare to negotiate with drug makers and enforcing price caps on
high-priced medicines for certain illnesses such as cancer, according to a
new poll from the Kaiser Family Foundation.

Moreover, two-thirds of Americans are in favor of creating an independent
group to oversee prices, 71 percent believe they should be able to import
medicines from Canada, and nearly 9 in 10 support the notion that drug
makers should be required to disclose information on how prices are set.

The survey, which queried more than 1,200 Americans, was conducted in
mid-September, shortly after controversy erupted over Mylan Pharmaceuticals
and its pricing strategy for EpiPen. But outrage has hardly been confined
to any one type of company or treatment.

Pricing concerns have spread to generics, which are traditionally
lower-cost alternatives to brand-name medicines, as well as new drugs for
hard-to-treat diseases, notably hepatitis C and some forms of cancer. And
prices for some older medicines, such as multiple sclerosis treatments, are
also climbing.

The issue has become so highly charged that drug prices are a talking point
in the presidential campaign, and federal and state lawmakers have
introduced legislation to contain rising costs, which 77 percent of
Americans believe are unreasonable. This is up from 72 percent a year ago,
according to Kaiser.

The survey, in fact, canvassed Americans on their reactions to some of the
proposals — old and new. For instance, 66 percent are in favor of creating
an independent group that would oversee pricing, a notion that Hillary
Clinton recently proposed.

The survey also found that 86 percent of Americans believe drug makers
should be required to disclose data used to set prices. In Washington, a
bipartisan group of lawmakers introduced a bill earlier this month, just as
the survey began, to disclose costs and justify certain price hikes. More
than a dozen states have introduced similar bills, although only Vermont
has passed such a law.

Yet there is less enthusiasm for other notions that have been floated.

Only 47 percent of those surveyed favor eliminating prescription drug ads,
which gained considerable attention last year when the American Medical
Association publicly called for a ban on such advertising. And only 42
percent support any policy that would encourage consumers to purchase
lower-cost drugs by requiring them to pay more for similar, but more
expensive medicines.

Paradoxically, few Americans say they have trouble paying for medicines.
Fifty-five percent reported taking prescription drugs and, of those, 73
percent say affordability is not an issue. But 42 percent who say their
health is fair or poor did report having difficulty. And 37 percent of
those currently taking four or more medications say cost is a problem,
compared to 19 percent taking less than four medications.

Despite their concerns over cost, 56 percent of Americans say that
prescription drugs developed over the past 20 years have generally improved

Zack Struver, Communications and Research Associate
Knowledge Ecology International
zack.struver at keionline.org
Twitter: @zstruver <https://twitter.com/zstruver>
Office: +1 (202) 332-2670 Cell: +1 (914) 582-1428

More information about the Ip-health mailing list